Nuclear imaging approaches facilitating nanomedicine translation.
暂无分享,去创建一个
Carlos Pérez-Medina | Abraham J P Teunissen | Ewelina Kluza | Willem J M Mulder | Roy van der Meel | R. van der Meel | W. Mulder | Carlos Pérez-Medina | A. Teunissen | E. Kluza | C. Pérez-Medina
[1] Josbert M. Metselaar,et al. Challenges in nanomedicine clinical translation , 2020, Drug Delivery and Translational Research.
[2] Feng Chen,et al. Intrinsically radiolabeled nanoparticles: an emerging paradigm. , 2014, Small.
[3] Yun Sun,et al. Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging. , 2011, Biomaterials.
[4] Lingzhou Zhao,et al. (131)I-labeled multifunctional dendrimers modified with BmK CT for targeted SPECT imaging and radiotherapy of gliomas. , 2016, Nanomedicine.
[5] Jordi Llop,et al. Tracing nanoparticles in vivo: a new general synthesis of positron emitting metal oxide nanoparticles by proton beam activation. , 2012, The Analyst.
[6] O. Tillement,et al. Synthesis and Characterization of (89)Zr-Labeled Ultrasmall Nanoparticles. , 2016, Molecular pharmaceutics.
[7] Klaus Kopka,et al. Encapsulating (111)In in nanocontainers for scintigraphic imaging: synthesis, characterization, and in vivo biodistribution. , 2010, ACS nano.
[8] Kai Yang,et al. Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer , 2017, Theranostics.
[9] C. Presant,et al. In-111-labeled liposomes: dosimetry and tumor depiction. , 1988, Radiology.
[10] Wei Feng,et al. Polyphosphoric acid capping radioactive/upconverting NaLuF4:Yb,Tm,153Sm nanoparticles for blood pool imaging in vivo. , 2013, Biomaterials.
[11] Z. Fayad,et al. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation , 2015, Science Advances.
[12] T. Beyer,et al. The future of hybrid imaging—part 3: PET/MR, small-animal imaging and beyond , 2011, Insights into imaging.
[13] Ande Bao,et al. Intraoperative 186Re-Liposome Radionuclide Therapy in a Head and Neck Squamous Cell Carcinoma Xenograft Positive Surgical Margin Model , 2008, Clinical Cancer Research.
[14] Ahmed Hosny,et al. Artificial intelligence in radiology , 2018, Nature Reviews Cancer.
[15] Lingzhou Zhao,et al. 131I‐Labeled Multifunctional Polyphosphazene Nanospheres for SPECT Imaging‐Guided Radiotherapy of Tumors , 2019, Advanced healthcare materials.
[16] A. Maitra,et al. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. , 2002, International journal of pharmaceutics.
[17] Jason S. Lewis,et al. Multiplexed imaging for diagnosis and therapy , 2017, Nature Biomedical Engineering.
[18] Zachary T. Rosenkrans,et al. Efficient Uptake of 177 Lu-Porphyrin-PEG Nanocomplexes by Tumor Mitochondria for Multimodal-Imaging-Guided Combination Therapy. , 2018, Angewandte Chemie.
[19] Serge K. Lyashchenko,et al. Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species , 2019, Science Translational Medicine.
[20] Marcus Hacker,et al. Personalizing Medicine Through Hybrid Imaging and Medical Big Data Analysis , 2018, Front. Phys..
[21] G. Loudos,et al. Molecular nanomedicine towards cancer: ¹¹¹In-labeled nanoparticles. , 2012, Journal of pharmaceutical sciences.
[22] W. Cai,et al. A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging. , 2017, Nanoscale.
[23] F. Kiessling,et al. Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects. , 2015, Chemical reviews.
[24] M. Manoharan,et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs , 2019, Nature Nanotechnology.
[25] Gal Chen,et al. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine , 2019, Advanced materials.
[26] Asgar Ali,et al. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[27] T. Ruth,et al. Accelerating production of medical isotopes , 2009, Nature.
[28] Bradley J. Beattie,et al. 89Zr-Labeled Paramagnetic Octreotide-Liposomes for PET-MR Imaging of Cancer , 2012, Pharmaceutical Research.
[29] D. Irvine,et al. Enhancing cancer immunotherapy with nanomedicine , 2020, Nature Reviews Immunology.
[30] Z. Fayad,et al. Imaging and Nanomedicine in Inflammatory Atherosclerosis , 2014, Science Translational Medicine.
[31] J. Pignol,et al. Stability and Biodistribution of Thiol-Functionalized and (177)Lu-Labeled Metal Chelating Polymers Bound to Gold Nanoparticles. , 2016, Biomacromolecules.
[32] Hélder A Santos,et al. Multifunctional porous silicon nanoparticles for cancer theranostics. , 2015, Biomaterials.
[33] A. D. Di Pasqua,et al. Neutron-Activatable Holmium-Containing Mesoporous Silica Nanoparticles as a Potential Radionuclide Therapeutic Agent for Ovarian Cancer , 2013, The Journal of Nuclear Medicine.
[34] Rubel Chakravarty,et al. Facile One‐Pot Synthesis of Intrinsically Radiolabeled 64Cu‐Human Serum Albumin Nanocomposite for Cancer Targeting , 2017 .
[35] Z. Fayad,et al. Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall. , 2019, Bioconjugate chemistry.
[36] R. Vile,et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] Z. Fayad,et al. An iterative sparse deconvolution method for simultaneous multicolor 19F‐MRI of multiple contrast agents , 2019, Magnetic resonance in medicine.
[38] G. Sundaresan,et al. [18F]-Fluorinated Carboplatin and [111In]-Liposome for Image-Guided Drug Delivery , 2017, International journal of molecular sciences.
[39] Kai Liu,et al. Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles. , 2012, ACS nano.
[40] D. Horák,et al. A simple neridronate-based surface coating strategy for upconversion nanoparticles: highly colloidally stable 125I-radiolabeled NaYF4:Yb3+/Er3+@PEG nanoparticles for multimodal in vivo tissue imaging. , 2017, Nanoscale.
[41] Guido Germano,et al. Recent Advances and Future Progress in PET Instrumentation. , 2016, Seminars in nuclear medicine.
[42] Minghao Sun,et al. Biodistribution and PET imaging of 89-zirconium labeled cerium oxide nanoparticles synthesized with several surface coatings. , 2018, Nanomedicine : nanotechnology, biology, and medicine.
[43] Z. Fayad,et al. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis , 2017, ACS nano.
[44] T. Lammers,et al. Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies , 2018, Molecular Imaging and Biology.
[45] Chih-Hsien Chang,et al. Biodistribution, pharmacokinetics and imaging of (188)Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model. , 2007, Nuclear medicine and biology.
[46] R. Weissleder,et al. Hybrid PET-optical imaging using targeted probes , 2010, Proceedings of the National Academy of Sciences.
[47] Ralph Weissleder,et al. Improving nanotherapy delivery and action through image-guided systems pharmacology , 2020, Theranostics.
[48] S. Solomon,et al. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis , 2018, The New England journal of medicine.
[49] Jennifer I. Hare,et al. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.
[50] Jeffrey A. Fessler,et al. Image Reconstruction is a New Frontier of Machine Learning , 2018, IEEE Transactions on Medical Imaging.
[51] Kai Yang,et al. Radionuclide (131)I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer. , 2015, Biomaterials.
[52] Silvia Muro,et al. In Vivo Imaging of 64Cu-Labeled Polymer Nanoparticles Targeted to the Lung Endothelium , 2007, Journal of Nuclear Medicine.
[53] K. Sunassee,et al. Biocompatible inorganic nanoparticles for [18F]-fluoride binding with applications in PET imaging. , 2011, Dalton transactions.
[54] F. Kiessling,et al. Nanomedicine and macroscale materials in immuno-oncology. , 2019, Chemical Society reviews.
[55] Ralph Weissleder,et al. Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques , 2013, Circulation research.
[56] E. Ruoslahti,et al. 64Cu-Labeled LyP-1-Dendrimer for PET-CT Imaging of Atherosclerotic Plaque , 2014, Bioconjugate chemistry.
[57] Hao Hong,et al. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery. , 2015, Nanomedicine.
[58] Manuela Semmler-Behnke,et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.
[59] Jordi Llop,et al. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes. , 2016, ACS nano.
[60] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[61] D. Kraitchman,et al. Probing in vivo trafficking of polymer/DNA micellar nanoparticles using SPECT/CT imaging. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[62] Jiye Shi,et al. Multiple-Armed Tetrahedral DNA Nanostructures for Tumor-Targeting, Dual-Modality in Vivo Imaging. , 2016, ACS applied materials & interfaces.
[63] A. Meijerink,et al. Investigating supramolecular systems using Förster resonance energy transfer. , 2018, Chemical Society reviews.
[64] K. Na,et al. 99mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imaging , 2010 .
[65] Raimo Hartmann,et al. In vivo integrity of polymer-coated gold nanoparticles. , 2015, Nature nanotechnology.
[66] Y. Liu,et al. Hydrothermal synthesis of NaLuF4:153Sm,Yb,Tm nanoparticles and their application in dual-modality upconversion luminescence and SPECT bioimaging. , 2013, Biomaterials.
[67] Aurelian Radu,et al. Near-infrared fluorescence energy transfer imaging of nanoparticle accumulation and dissociation kinetics in tumor-bearing mice. , 2013, ACS nano.
[68] Axel Thran,et al. Atherosclerotic Plaque Composition : Analysis with Multicolor CT and Targeted Gold Nanoparticles 1 , 2010 .
[69] Liming Wang,et al. Quantification of Nanomaterial/Nanomedicine Trafficking in Vivo. , 2018, Analytical chemistry.
[70] Wen Jiang,et al. Designing nanomedicine for immuno-oncology , 2017, Nature Biomedical Engineering.
[71] Benjamin R. Jarrett,et al. Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. , 2008, Bioconjugate chemistry.
[72] Deborah Pareto,et al. Biodistribution of amino-functionalized diamond nanoparticles. In vivo studies based on 18F radionuclide emission. , 2011, ACS nano.
[73] Yong Ding,et al. Self-Illuminating 64Cu-Doped CdSe/ZnS Nanocrystals for in Vivo Tumor Imaging , 2014, Journal of the American Chemical Society.
[74] Chih-Hsien Chang,et al. Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of (188)Re-DXR-liposome in C26 colon carcinoma ascites mice model. , 2008, Nuclear medicine and biology.
[75] Stuart S Berr,et al. PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes. , 2012, Biomaterials.
[76] A. J. Tavares,et al. Analysis of nanoparticle delivery to tumours , 2016 .
[77] A. Agarwal,et al. Dual-mode imaging with radiolabeled gold nanorods. , 2011, Journal of biomedical optics.
[78] A. Packard,et al. Molecular imaging in nanomedicine - A developmental tool and a clinical necessity. , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[79] B. Hendriks,et al. Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study , 2018, British Journal of Cancer.
[80] P. Scott,et al. Novel strategies for fluorine-18 radiochemistry. , 2012, Angewandte Chemie.
[81] Jean-Philippe Pignol,et al. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer , 2016, The Journal of Nuclear Medicine.
[82] Hamidreza Ghandehari,et al. Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors. , 2014, Nuclear medicine and biology.
[83] V. Caps,et al. Carbon‐Encapsulated Radioactive 99mTc Nanoparticles , 2004 .
[84] Hao Hong,et al. cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. , 2011, Biomaterials.
[85] L. McManus,et al. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. , 2011, Radiology.
[86] Simon R. Cherry,et al. A Smart and Versatile Theranostic Nanomedicine Platform based on Nanoporphyrin , 2014, Nature Communications.
[87] Z. Fayad,et al. Integrating nanomedicine and imaging , 2017, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[88] Chad A Mirkin,et al. Exploration of the nanomedicine-design space with high-throughput screening and machine learning , 2019, Nature Biomedical Engineering.
[89] Fabian Kiessling,et al. Smart cancer nanomedicine , 2019, Nature Nanotechnology.
[90] A. Giatromanolaki,et al. High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy. , 2000, Acta oncologica.
[91] Andreas Kjær,et al. Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes. , 2015, ACS nano.
[92] R. Weissleder,et al. 89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. , 2011, Bioconjugate chemistry.
[93] D. Feng,et al. 131I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization , 2018, Theranostics.
[94] Sung Jin Cho,et al. Engineering of Radioiodine-Labeled Gold Core-Shell Nanoparticles As Efficient Nuclear Medicine Imaging Agents for Trafficking of Dendritic Cells. , 2017, ACS applied materials & interfaces.
[95] Z. Fayad,et al. A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis. , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[96] A. Denkova,et al. The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier , 2019, Scientific Reports.
[97] Leyong Wang,et al. New light on the ring-chain equilibrium of a hydrogen-bonded supramolecular polymer based on a photochromic dithienylethene unit and its energy-transfer properties as a storage material. , 2011, Chemistry.
[98] Zahi A Fayad,et al. Real-Time Monitoring of Nanoparticle Formation by FRET Imaging. , 2017, Angewandte Chemie.
[99] Jason P. Holland,et al. Advanced Methods for Radiolabeling Multimodality Nanomedicines for SPECT/MRI and PET/MRI , 2017, The Journal of Nuclear Medicine.
[100] Kristofer J. Thurecht,et al. Bridging Bio-Nano Science and Cancer Nanomedicine. , 2017, ACS nano.
[101] Greg M Thurber,et al. 18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.
[102] Z. Fayad,et al. Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging , 2020, Nature Nanotechnology.
[103] Christopher B. Murray,et al. Shape-Controlled Synthesis of Isotopic Yttrium-90-Labeled Rare Earth Fluoride Nanocrystals for Multimodal Imaging. , 2015, ACS nano.
[104] Mithat Gönen,et al. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe , 2014, Science Translational Medicine.
[105] T. Andresen,et al. In vivo evaluation of PEGylated 64Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[106] Feng Chen,et al. Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics☆ , 2017, Advanced drug delivery reviews.
[107] M. Shamsipur,et al. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions. , 2018, Journal of biomedical materials research. Part A.
[108] Jordi Llop,et al. Biodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particles. , 2013, ACS nano.
[109] T. Beyer,et al. The future of hybrid imaging—part 1: hybrid imaging technologies and SPECT/CT , 2011, Insights into imaging.
[110] J. Lagares,et al. Production of 18F‐Labeled Titanium Dioxide Nanoparticles by Proton Irradiation for Biodistribution and Biological Fate Studies in Rats , 2014 .
[111] Andreas Kjær,et al. Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[112] Travis M. Shaffer,et al. Near-Infrared Quantum Dot and 89Zr Dual-Labeled Nanoparticles for in Vivo Cerenkov Imaging. , 2017, Bioconjugate chemistry.
[113] T. Okauchi,et al. Positron emission tomography with additional γ‐ray detectors for multiple‐tracer imaging , 2017, Medical physics.
[114] Xin Cai,et al. Radioactive 198Au-Doped Nanostructures with Different Shapes for In Vivo Analyses of Their Biodistribution, Tumor Uptake, and Intratumoral Distribution , 2014, ACS nano.
[115] Robert K. Stuart,et al. CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[116] Xiaoyuan Chen,et al. Polymeric Nanoparticles with a Glutathione-Sensitive Heterodimeric Multifunctional Prodrug for In Vivo Drug Monitoring and Synergistic Cancer Therapy. , 2018, Angewandte Chemie.
[117] Emily B. Ehlerding,et al. Multimodality Imaging Agents with PET as the Fundamental Pillar. , 2019, Angewandte Chemie.
[118] P. Perriat,et al. Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging. , 2015, Contrast media & molecular imaging.
[119] Karen Campbell,et al. 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer , 2017, Clinical Cancer Research.
[120] F. Ginhoux,et al. Inhibiting Inflammation with Myeloid Cell‐Specific Nanobiologics Promotes Organ Transplant Acceptance , 2018, Immunity.
[121] Daniel G. Anderson,et al. Strategies, design, and chemistry in siRNA delivery systems. , 2019, Advanced drug delivery reviews.
[122] Z. Fayad,et al. Imaging-guided revival of nanomedicine? , 2017, Nanomedicine.
[123] R. I. Jølck,et al. Remote loading of liposomes with a 124I-radioiodinated compound and their in vivo evaluation by PET/CT in a murine tumor model , 2018, Theranostics.
[124] Yan Xing,et al. Radiolabeled Nanoparticles for Multimodality Tumor Imaging , 2014, Theranostics.
[125] Silvia Muro,et al. Endothelial targeting of polymeric nanoparticles stably labeled with the PET imaging radioisotope iodine-124. , 2012, Biomaterials.
[126] P. Lambin,et al. Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.
[127] Johan Axelsson,et al. (68)Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes. , 2013, American journal of nuclear medicine and molecular imaging.
[128] Younan Xia,et al. Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. , 2013, Nano letters.
[129] T. Kissel,et al. In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure. , 2009, Bioconjugate chemistry.
[130] K. Doi,et al. Computer-aided diagnosis and artificial intelligence in clinical imaging. , 2011, Seminars in nuclear medicine.
[131] J. Schnitzer,et al. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging , 2010, International journal of nanomedicine.
[132] V. Fuster,et al. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. , 2016, JACC. Cardiovascular imaging.
[133] A. Louie,et al. Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging. , 2011, Bioconjugate chemistry.
[134] F. Albericio,et al. Synthesis and in vivo evaluation of the biodistribution of a 18F-labeled conjugate gold-nanoparticle-peptide with potential biomedical application. , 2012, Bioconjugate chemistry.
[135] Valerie A Longo,et al. A Modular Labeling Strategy for In Vivo PET and Near-Infrared Fluorescence Imaging of Nanoparticle Tumor Targeting , 2014, The Journal of Nuclear Medicine.
[136] Zahi A. Fayad,et al. Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy , 2016, Nature Communications.
[137] Arkadiusz Sitek,et al. EM reconstruction of Dual Isotope PET with staggered injections and prompt gamma positron emitters , 2012, 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSS/MIC).
[138] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[139] Karen L Wooley,et al. Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. , 2014, Angewandte Chemie.
[140] G. Cavallo,et al. Magnetic Resonance Imaging ( MRI ) : From Design of Materials to Clinical Applications , 2014 .
[141] Samuel Achilefu,et al. Dual-radiolabeled nanoparticle SPECT probes for bioimaging. , 2015, Nanoscale.
[142] K. Harrington,et al. The Biodistribution and Pharmacokinetics of Stealth Liposomes in Patients with Solid Tumors , 1997 .
[143] Xiaoyuan Chen,et al. Efficient screening of spherical nucleic acids , 2019, Nature Biomedical Engineering.
[144] Zhen Yuan,et al. PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. , 2015, Quantitative imaging in medicine and surgery.
[145] U. Haberkorn,et al. Cancer Stratification by Molecular Imaging , 2015, International journal of molecular sciences.
[146] Jongho Jeon. Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials , 2019, International journal of molecular sciences.
[147] Zahi A. Fayad,et al. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles , 2015, The Journal of Nuclear Medicine.
[148] Y. Hao,et al. Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors , 2016, Scientific Reports.
[149] Bin Zhang,et al. Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates , 2018, Nature Biomedical Engineering.
[150] Dale L. Bailey,et al. Quantitative SPECT/CT: SPECT joins PET as a quantitative imaging modality , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[151] Jordi Llop,et al. 68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. , 2014, Journal of the American Chemical Society.
[152] S. Kennel,et al. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides. , 2011, Bioconjugate chemistry.
[153] David A Scheinberg,et al. Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes , 2010, International journal of nanomedicine.
[154] A Celler,et al. Dual-isotope PET using positron-gamma emitters , 2011, Physics in medicine and biology.
[155] Z. Fayad,et al. High-Density Lipoprotein Nanobiologics for Precision Medicine. , 2018, Accounts of chemical research.
[156] M. Meyerand,et al. Intrinsically Germanium‐69‐Labeled Iron Oxide Nanoparticles: Synthesis and In‐Vivo Dual‐Modality PET/MR Imaging , 2014, Advanced materials.
[157] D. Scheinberg,et al. Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes , 2007, Journal of Nuclear Medicine.
[158] Indrajit Roy,et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. , 2010, ACS nano.
[159] T. Andresen,et al. Theranostic Imaging May Vaccinate against the Therapeutic Benefit of Long Circulating PEGylated Liposomes and Change Cargo Pharmacokinetics. , 2018, ACS nano.
[160] Weibo Cai,et al. Positron emission tomography imaging using radiolabeled inorganic nanomaterials. , 2015, Accounts of chemical research.
[161] C. S. Lim,et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping , 2010, Nature.
[162] F. Man,et al. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine , 2019, Advanced drug delivery reviews.
[163] A. Paul Alivisatos,et al. Cation Exchange: A Versatile Tool for Nanomaterials Synthesis , 2013 .
[164] Ali Azhdarinia,et al. Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging. , 2014, Nanomedicine.
[165] Keila Isaac-Olivé,et al. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells. , 2013, Journal of labelled compounds & radiopharmaceuticals.
[166] Min-Hua Chen,et al. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model. , 2010, Nuclear medicine and biology.
[167] Wei Feng,et al. Radioisotope post-labeling upconversion nanophosphors for in vivo quantitative tracking. , 2013, Biomaterials.
[168] E. Hersh,et al. Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. , 1984, Cancer research.
[169] Jordi Llop,et al. Visualisation of dual radiolabelled poly(lactide-co-glycolide) nanoparticle degradation in vivo using energy-discriminant SPECT. , 2015, Journal of materials chemistry. B.
[170] Michael J Welch,et al. Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications. , 2012, Bioconjugate chemistry.
[171] Thomas Kull,et al. Quantitative and correlative biodistribution analysis of 89Zr-labeled mesoporous silica nanoparticles intravenously injected into tumor-bearing mice. , 2017, Nanoscale.
[172] Luis Martí-Bonmatí,et al. Multimodality imaging techniques. , 2010, Contrast media & molecular imaging.
[173] A. Celler,et al. Dual-radioisotope PET data acquisition and analysis , 2011, 2011 IEEE Nuclear Science Symposium Conference Record.
[174] Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated 177Lu-Labeled Folic Acid Using SPECT/CT Imaging of Mice. , 2019, Molecular pharmaceutics.
[175] Mingyuan Gao,et al. In situ 111In-doping for achieving biocompatible and non-leachable 111In-labeled Fe3O4 nanoparticles. , 2014, Chemical communications.
[176] B. Cornelissen,et al. Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours☆☆☆ , 2019, Nuclear medicine and biology.
[177] S. Wilhelm,et al. The entry of nanoparticles into solid tumours , 2020, Nature Materials.
[178] Vanessa Gómez-Vallejo,et al. Novel 18F labeling strategy for polyester-based NPs for in vivo PET-CT imaging. , 2015, Bioconjugate chemistry.
[179] Ralf Schirrmacher,et al. Rapid (18)F-labeling and loading of PEGylated gold nanoparticles for in vivo applications. , 2014, Bioconjugate chemistry.
[180] F J Beekman,et al. In vivo biodistribution of stable spherical and filamentous micelles probed by high-sensitivity SPECT. , 2016, Biomaterials science.
[181] M. Ivanovic,et al. Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer , 2016, Cancer Chemotherapy and Pharmacology.
[182] W. Moses,et al. Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care , 2018, The Journal of Nuclear Medicine.
[183] Ciprian Catana,et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.
[184] Feng Chen,et al. In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles , 2015, ACS nano.
[185] Diederik F Van Wijk,et al. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[186] Klaas Nicolay,et al. 89Zr‐ and Fe‐Labeled Polymeric Micelles for Dual Modality PET and T1‐Weighted MR Imaging , 2015, Advanced healthcare materials.
[187] Dong Liang,et al. A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. , 2010, Journal of the American Chemical Society.
[188] S. Nie,et al. Luminescent quantum dots for multiplexed biological detection and imaging. , 2002, Current opinion in biotechnology.
[189] Gang Zheng,et al. Intrinsically copper-64-labeled organic nanoparticles as radiotracers. , 2012, Angewandte Chemie.
[190] A. McMillan,et al. Deep learning Mr imaging–based attenuation correction for PeT/Mr imaging 1 , 2017 .
[191] S. Bossmann,et al. Incorporating 131I into a PAMAM (G5.0) dendrimer-conjugate: design of a theranostic nanosensor for medullary thyroid carcinoma , 2017 .
[192] Valerie A Longo,et al. Immune cell screening of a nanoparticle library improves atherosclerosis therapy , 2016, Proceedings of the National Academy of Sciences.
[193] Pei Zou,et al. Enzyme-Controlled Intracellular Self-Assembly of 18F Nanoparticles for Enhanced MicroPET Imaging of Tumor , 2015, Theranostics.
[194] V. Muzykantov,et al. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities , 2012, Science.
[195] D. Scheinberg,et al. Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers , 2007 .
[196] K. Lam,et al. “One-Pot” Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics , 2017, Theranostics.
[197] N. Harada,et al. Development of double-stranded siRNA labeling method using positron emitter and its in vivo trafficking analyzed by positron emission tomography. , 2010, Bioconjugate chemistry.
[198] Yadong Yin,et al. Cation Exchange Reactions in Ionic Nanocrystals , 2004, Science.
[199] Wim E Hennink,et al. Cancer nanomedicines: oversold or underappreciated? , 2017, Expert opinion on drug delivery.
[200] Hiroshi Maeda,et al. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. , 2015, Advanced drug delivery reviews.
[201] S. Alzghari,et al. Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[202] Bernd J Pichler,et al. Combined PET/MR: A Technology Becomes Mature , 2015, The Journal of Nuclear Medicine.
[203] Yun Sun,et al. Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging. , 2013, ACS nano.
[204] R. Boellaard,et al. PET/CT and PET/MR Tomographs: Image Acquisition and Processing , 2019, Nuclear Medicine Textbook.
[205] Fuping Gao,et al. Ultrasmall [(64)Cu]Cu nanoclusters for targeting orthotopic lung tumors using accurate positron emission tomography imaging. , 2015, ACS nano.
[206] G. Loudos,et al. Radiolabeling approaches of nanoparticles with (99m) Tc. , 2013, Contrast media & molecular imaging.
[207] A. Aliev,et al. Chemoradiotherapeutic Magnetic Nanoparticles for Targeted Treatment of Nonsmall Cell Lung Cancer. , 2015, Molecular pharmaceutics.
[208] Jiye Shi,et al. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury , 2018, Nature Biomedical Engineering.
[209] A. Bao,et al. [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model. , 2009, Nuclear medicine and biology.
[210] Hongwei Wu,et al. Radioactive Nanomaterials for Multimodality Imaging , 2016, Tomography.
[211] Juan Pellico,et al. Fast synthesis and bioconjugation of (68) Ga core-doped extremely small iron oxide nanoparticles for PET/MR imaging. , 2016, Contrast media & molecular imaging.
[212] M. Dewhirst,et al. A Tracer Dose of Technetium-99m–Labeled Liposomes Can Estimate the Effect of Hyperthermia on Intratumoral Doxil Extravasation , 2006, Clinical Cancer Research.
[213] T. Ishida,et al. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[214] Dong Liang,et al. Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts. , 2011, Biomaterials.
[215] S. Cherry,et al. Innovations in Instrumentation for Positron Emission Tomography. , 2018, Seminars in nuclear medicine.
[216] Thomas Beyer,et al. The future of hybrid imaging—part 2: PET/CT , 2011, Insights into imaging.
[217] H. Wolterbeek,et al. A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters? , 2015, Pharmaceuticals.
[218] Duxin Sun,et al. Noninvasive fluorescence resonance energy transfer imaging of in vivo premature drug release from polymeric nanoparticles. , 2013, Molecular pharmaceutics.
[219] T. Park,et al. Diverse Applications of Nanomedicine , 2017, ACS nano.
[220] Igor L. Medintz,et al. Self-assembled nanoscale biosensors based on quantum dot FRET donors , 2003, Nature materials.
[221] Sanjiv S Gambhir,et al. Self-illuminating quantum dot conjugates for in vivo imaging , 2006, Nature Biotechnology.
[222] H. Wolterbeek,et al. Improved 225Ac daughter retention in InPO4 containing polymersomes. , 2017, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[223] Ick Chan Kwon,et al. Facile method to radiolabel glycol chitosan nanoparticles with (64)Cu via copper-free click chemistry for MicroPET imaging. , 2013, Molecular pharmaceutics.
[224] Sanjiv S Gambhir,et al. Synthesis of ligand-functionalized water-soluble [18F]YF3 nanoparticles for PET imaging. , 2013, Nanoscale.
[225] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[226] Robert Langer,et al. Delivery technologies for cancer immunotherapy , 2019, Nature Reviews Drug Discovery.
[227] Yongyi Yang,et al. Machine Learning in Medical Imaging , 2010, IEEE Signal Processing Magazine.
[228] A. Giatromanolaki,et al. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[229] Roger Y. Tsien,et al. Paramagnetic fluorinated nanoemulsions for sensitive cellular fluorine-19 magnetic resonance imaging , 2016, Nature materials.
[230] R. Korn,et al. Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study , 2017, Clinical Cancer Research.
[231] B. Ahn,et al. Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma , 2017, International journal of molecular sciences.
[232] Jiang Liu,et al. FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia , 2018, Clinical Cancer Research.
[233] Eric D. Pressly,et al. Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. , 2007, Biomacromolecules.
[234] L. Joosten,et al. Therapeutic targeting of trained immunity , 2019, Nature Reviews Drug Discovery.
[235] Wen Shi,et al. The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging. , 2014, Biomaterials.
[236] B. Hendriks,et al. Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines , 2018, Theranostics.
[237] David Izquierdo-Garcia,et al. A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation , 2014, Nature Communications.
[238] C. Presant,et al. Successful imaging of human cancer with indium‐111‐labeled phospholipid vesicles , 1988, Cancer.
[239] Jinhua Zhao,et al. Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas. , 2015, ACS applied materials & interfaces.